Dr. Anna Zezon is a passionate, curious internist focusing on geriatric care and serving patients in New York City. She received her medical degree from the Sackler School of Medicine in Tel Aviv, Israel, then moved back to New York City to complete her geriatric fellowship at the New York University School of Medicine. Dr. Zezon is certified in internal medicine by the American Board of Internal Medicine, and also holds certification in basic life support and advanced cardiac life support.
Emphasizing the elevation of quality-of-life, Dr. Zezon strives to foster positive, long-term relationships with her patients. Her practice is centered on understanding the complexity of geriatric illnesses, diseases, and disorders to provide the highest standard of care to her patients.
Patients visiting Dr. Zezon can receive a full range of medical services. She provides treatment for specific illnesses and issues, as well as general medical consultations. Dr. Zezon has also published her research concerning rheumatoid arthritis in relation to autoimmune thyroid disease.
Medical School - Sackler School of Medicine
Albert Einstein College of Medicine of Yeshiva University, Jacobi Medical Center, Internship in Internal Medicine
Albert Einstein College of Medicine of Yeshiva University, Jacobi Medical Center, Residency in Internal Medicine
New York University Elaine A. and Kenneth G. Langone Medical Center, Fellowship in Geriatrics
Columbia University, Barnard College (Bachelor’s)
American Board of Internal Medicine
Geriatric Medicine (Internal Medicine)
Awards and Publications
Clement E. Tagoe, Anna Zezon and Saakshi Khattri: Rheumatic Manifestations of Autoimmune Thyroid Disease: The other Autoimmune Disease. J Rheum June 2012 39 (6) : 1125-1129; published online before print, April 15, 2012.
Clement E. Tagoe, Anna Zezon, Patricia Castellanos, Saakshi Khattri: Rheumatic Manifestations of euthyroid, anti-thyroid antibody positive patients. Rheumatology International (Clinical and Experimental Investigations) Accepted for publication on September 12, 2012.